RT Journal Article
SR Electronic
T1 Epidemiological and clinical features of COVID-19 patients with and without pneumonia in Beijing, China
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.02.28.20028068
DO 10.1101/2020.02.28.20028068
A1 Yang, Penghui
A1 Ding, Yibo
A1 Xu, Zhe
A1 Pu, Rui
A1 Li, Ping
A1 Yan, Jin
A1 Liu, Jiluo
A1 Meng, Fanping
A1 Huang, Lei
A1 Shi, Lei
A1 Jiang, Tianjun
A1 Qin, Enqiang
A1 Zhao, Min
A1 Zhang, Dawei
A1 Zhao, Peng
A1 Yu, Lingxiang
A1 Wang, Zhaohai
A1 Hong, Zhixian
A1 Xiao, Zhaohui
A1 Xi, Qing
A1 Zhao, Dexi
A1 Yu, Peng
A1 Zhu, Caizhong
A1 Chen, Zhu
A1 Zhang, Shaogeng
A1 Ji, Junsheng
A1 Cao, Guangwen
A1 Wang, Fusheng
YR 2020
UL http://medrxiv.org/content/early/2020/03/03/2020.02.28.20028068.abstract
AB Background SARS-CoV-2-caused coronavirus disease (COVID-19) is posing a large casualty. The features of COVID-19 patients with and without pneumonia, SARS-CoV-2 transmissibility in asymptomatic carriers, and factors predicting disease progression remain unknown.Methods We collected information on clinical characteristics, exposure history, and laboratory examinations of all laboratory-confirmed COVID-19 patients admitted to PLA General Hospital. Cox regression analysis was applied to identify prognostic factors. The last follow-up was February 18, 2020.Results We characterized 55 consecutive COVID-19 patients. The mean incubation was 8.42 (95% confidence interval [CI], 6.55-10.29) days. The mean SARS-CoV-2-positive duration from first positive test to conversion was 9.71 (95%CI, 8.21-11.22) days. COVID-19 course was approximately 2 weeks. Asymptomatic carriers might transmit SARS-CoV-2. Compared to patients without pneumonia, those with pneumonia were 15 years older and had a higher rate of hypertension, higher frequencies of having a fever and cough, and higher levels of interleukin-6 (14.61 vs. 8.06pg/mL, P=0.040), B lymphocyte proportion (13.0% vs.10.0%, P=0.024), low account (<190/µL) of CD8+ T cells (33.3% vs. 0, P=0.019). Multivariate Cox regression analysis indicated that circulating interleukin-6 and lactate independently predicted COVID-19 progression, with a hazard ratio (95%CI) of 1.052 (1.000-1.107) and 1.082 (1.013-1.155), respectively. During disease course, T lymphocytes were generally lower, neutrophils higher, in pneumonia patients than in pneumonia-free patients. CD8+ lymphocytes did not increase at the 20th days after illness onset.Conclusion The epidemiological features are important for COVID-19 prophylaxis. Circulating interleukin-6 and lactate are independent prognostic factors. CD8+ T cell exhaustion might be critical in the development of COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was partly supported by an environmental health project (AWS16J023 to Guangwen Cao) from Chinese military system.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesOriginal data are open.